Edges in Network
Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | TADA3 |
Upstream (Parents) |
---|
(<<) CUX2 → TADA3 |
(<<) HOXD11 → TADA3 |
(<<) HOXD4 → TADA3 |
(<<) SOX2 → TADA3 |
(<<) NPAS1 → TADA3 |
(<<) HEY1 → TADA3 |
(<<) PAX4 → TADA3 |
(<<) SOX9 → TADA3 |
(<<) ZNF81 → TADA3 |
(<<) YY1 → TADA3 |
(<<) C11orf9 → TADA3 |
(<<) MLLT10 → TADA3 |
(<<) PURA → TADA3 |
(<<) ZNF45 → TADA3 |
(<<) HOXC4 → TADA3 |
(<<) BCL11B → TADA3 |
Downstream (Children) |
---|
TADA3 → ST18 (>>) |
TADA3 → SP140 (>>) |
TADA3 → MYF6 (>>) |
TADA3 → RUNX2 (>>) |
TADA3 → BARX1 (>>) |
TADA3 → MYF5 (>>) |